Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

This publication has 26 references indexed in Scilit:

• Crystals of the urokinase type plasminogen activator variant βc-uPA in complex with small molecule inhibitors open the way towards structure-based drug design
  Journal of Molecular Biology, 2000
• (4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase
  Proceedings of the National Academy of Sciences, 2000
• Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite
  Structure, 2000
• Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator
  Chemistry & Biology, 2000
• Re-engineering of Human Urokinase Provides a System for Structure-based Drug Design at High Resolution and Reveals a Novel Structural Subsite
  Published by Elsevier ,2000
• Emerging therapeutic targets in oncology: urokinase-type plasminogen activator system
  Emerging Therapeutic Targets, 1999
• The urokinase-type plasminogen activator system in cancer metastasis: A review
  International Journal of Cancer, 1997
• Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA)
  International Journal of Cancer, 1995
• Selective inhibition of urokinase by substituted phenylguanidines: quantitative structure-activity relationship analyses
  Journal of Medicinal Chemistry, 1990
• Plasminogen Activators, Tissue Degradation, and Cancer
  Published by Elsevier ,1985